Status:
UNKNOWN
TCM Constitution, Pattern Types, and Disease Factors in Primary Lung Cancer.
Lead Sponsor:
China Medical University Hospital
Conditions:
Medicine, Chinese Traditional
Body Constitution
Eligibility:
All Genders
18-100 years
Brief Summary
Recently, TCM has played an important role in adjuvant therapy for lung cancer. TCM treatment is based on pattern identification, and constitution theory is also used as a tool for TCM to predict the ...
Eligibility Criteria
Inclusion
- Patients diagnosed with primary lung cancer.
- Age greater than 18 years and less than 100 years.
- After explanation, they agree to join this study and voluntarily sign the subject consent form, and can understand the content of the questionnaire.
Exclusion
- Pregnant women.
- Severe mental illness that affects the response to the questionnaire.
- Has been treated (e.g., surgery, chemotherapy, targeted therapy, immunotherapy, radiation therapy, etc.).
- Concomitant with other uncured primary malignancies.
- Patients with other serious primary diseases (such as: liver and kidney dysfunction, hematolymphatic system diseases, etc.).
- Severe respiratory diseases that are not lung cancer (e.g. primary emphysema, interstitial fibrosis, etc.) .
Key Trial Info
Start Date :
December 20 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 19 2025
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06143436
Start Date
December 20 2023
End Date
May 19 2025
Last Update
January 2 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
China Medical University Hospital
Taichung, Taiwan